Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
FTRE is expected to report earnings to rise 341.67% to 52 cents per share on March 16
Q4'25
Est.
$0.53
Q3'25
Missed
by $0.36
Q2'25
Beat
by $0.11
Q1'25
Missed
by $0.39
Q4'24
Missed
by $0.24
The last earnings report on November 05 showed earnings per share of 11 cents, missing the estimate of 47 cents. With 821.39K shares outstanding, the current market capitalization sits at 1.65B.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. FTRE showed earnings on November 05, 2025. You can read more about the earnings report here.